Geneseeq Technology
Connie Y. is the Director Global Business Development at Geneseeq Technology Inc. and a PhD Student at the University of Toronto. Connie has experience in molecular genetics and is currently working on the cellular basis for RAF1 mutant-associated Noonan syndrome cardiomyopathy. Connie previously worked as an Undergraduate Thesis Student, where Connie assisted in identifying the molecular mechanism by which RAF1 acts to promote Noonan syndrome pathogenesis.
This person is not in any offices
Geneseeq Technology
1 followers
Geneseeq is a research-driven company providing cutting-edge next-generation sequencing (NGS) technology to accelerate precision cancer care.